Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADMANYSE:CYHNASDAQ:HCATNASDAQ:HROW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADMAADMA Biologics$20.45+2.4%$20.28$8.42▼$25.67$4.86B0.573.72 million shs4.58 million shsCYHCommunity Health Systems$3.88+10.7%$2.71$2.24▼$6.29$543.69M1.992.24 million shs4.74 million shsHCATHealth Catalyst$4.52+9.4%$4.13$3.56▼$9.24$317.35M1.56601,382 shs671,418 shsHROWHarrow$26.66+9.3%$24.80$11.39▼$59.23$978.02M0.41510,775 shs699,757 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADMAADMA Biologics0.00%-15.01%+3.04%+19.99%+126.90%CYHCommunity Health Systems0.00%+23.67%+41.41%+3.40%+8.36%HCATHealth Catalyst0.00%-1.19%+5.34%-28.00%-35.41%HROWHarrow0.00%-5.54%+1.29%-23.75%+110.34%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADMAADMA Biologics2.1368 of 5 stars2.61.00.00.03.21.71.9CYHCommunity Health Systems3.0963 of 5 stars2.01.00.04.52.92.50.6HCATHealth Catalyst4.4531 of 5 stars4.41.00.03.82.52.51.3HROWHarrow2.0539 of 5 stars3.51.00.00.02.02.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADMAADMA Biologics 3.25Buy$24.2518.58% UpsideCYHCommunity Health Systems 2.00Hold$3.921.08% UpsideHCATHealth Catalyst 2.70Moderate Buy$8.0076.99% UpsideHROWHarrow 3.00Buy$61.25129.74% UpsideCurrent Analyst Ratings BreakdownLatest CYH, HROW, HCAT, and ADMA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/12/2025HROWHarrowHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$57.00 ➝ $60.005/8/2025ADMAADMA BiologicsRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetStrong-Buy ➝ Strong-Buy$25.00 ➝ $32.005/8/2025HCATHealth CatalystCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $9.005/8/2025HCATHealth CatalystStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$5.00 ➝ $5.504/25/2025CYHCommunity Health SystemsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$3.504/25/2025HCATHealth CatalystCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$7.00 ➝ $6.504/16/2025HCATHealth CatalystKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$7.00 ➝ $5.004/11/2025CYHCommunity Health SystemsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$4.00 ➝ $3.004/9/2025CYHCommunity Health SystemsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral4/9/2025HCATHealth CatalystEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Inline4/9/2025HCATHealth CatalystEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ In-Line$6.00 ➝ $4.00(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADMAADMA Biologics$459.38M10.58$0.07 per share311.70$0.60 per share34.08CYHCommunity Health Systems$12.65B0.04$2.77 per share1.40($12.06) per share-0.32HCATHealth Catalyst$311.27M1.02N/AN/A$6.38 per share0.71HROWHarrow$199.61M4.90N/AN/A$2.01 per share13.26Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADMAADMA Biologics-$28.24M$0.8573.0429.64N/A17.80%53.20%26.07%N/ACYHCommunity Health Systems-$133M-$3.68N/A15.50N/A-4.08%N/A-0.96%7/23/2025 (Estimated)HCATHealth Catalyst-$118.15M-$1.15N/AN/AN/A-26.20%-7.51%-3.72%N/AHROWHarrow-$24.41M-$0.44N/A66.65N/A-19.75%-45.57%-8.87%N/ALatest CYH, HROW, HCAT, and ADMA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025HROWHarrow$0.02-$0.38-$0.40-$0.50$57.00 million$47.83 million5/7/2025Q1 2025ADMAADMA Biologics$0.16$0.14-$0.02$0.11$116.40 million$114.80 million4/23/2025Q1 2025CYHCommunity Health Systems-$0.10-$0.03+$0.07-$0.10$3.10 billion$3.16 billion3/27/2025Q4 2024HROWHarrow$0.11$0.25+$0.14$0.24$66.01 million$66.83 million2/18/2025Q4 2024CYHCommunity Health Systems$0.09-$0.42-$0.51-$0.53$3.14 billion$3.27 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADMAADMA BiologicsN/AN/AN/AN/AN/ACYHCommunity Health SystemsN/AN/AN/AN/AN/AHCATHealth CatalystN/AN/AN/AN/AN/AHROWHarrowN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADMAADMA Biologics0.487.093.26CYHCommunity Health SystemsN/A1.411.32HCATHealth Catalyst0.321.411.41HROWHarrow3.231.551.44Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADMAADMA Biologics75.68%CYHCommunity Health Systems84.99%HCATHealth Catalyst85.00%HROWHarrow72.76%Insider OwnershipCompanyInsider OwnershipADMAADMA Biologics3.50%CYHCommunity Health Systems11.70%HCATHealth Catalyst2.50%HROWHarrow15.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADMAADMA Biologics530237.62 million227.64 millionOptionableCYHCommunity Health Systems66,000140.31 million125.19 millionOptionableHCATHealth Catalyst1,20070.21 million59.33 millionOptionableHROWHarrow18236.69 million30.75 millionOptionableCYH, HROW, HCAT, and ADMA HeadlinesRecent News About These Companies24,624 Shares in Harrow, Inc. (NASDAQ:HROW) Acquired by Centiva Capital LPMay 11 at 6:02 AM | marketbeat.comHarrow (NASDAQ:HROW) Shares Gap Down After Earnings MissMay 11 at 1:37 AM | americanbankingnews.comHarrow, Inc. (HROW) Q1 2025 Earnings Call TranscriptMay 10 at 7:00 PM | seekingalpha.comHarrow Inc (HROW) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Market ...May 10 at 5:11 AM | finance.yahoo.comExamining the Future: Harrow's Earnings OutlookMay 9 at 7:10 PM | nasdaq.comHarrow Health Posts Larger Loss In Q1, But Retail Enthusiasm Grows As Dry Eye Disease Drug Drives RevenueMay 9 at 9:06 AM | msn.comHarrow (HROW) Reports Q1 Loss, Lags Revenue EstimatesMay 8, 2025 | zacks.comHarrow Announces First-Quarter 2025 Financial ResultsMay 8, 2025 | businesswire.comBraidwell LP Buys 467,401 Shares of Harrow, Inc. (NASDAQ:HROW)May 8, 2025 | marketbeat.comHarrow (HROW) to Release Quarterly Earnings on MondayMay 7, 2025 | marketbeat.comFreestone Grove Partners LP Purchases New Holdings in Harrow, Inc. (NASDAQ:HROW)May 7, 2025 | marketbeat.comInvesco Ltd. Lowers Position in Harrow, Inc. (NASDAQ:HROW)May 6, 2025 | marketbeat.comHarrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025May 5, 2025 | businesswire.comJPMorgan Chase & Co. Lowers Stock Position in Harrow, Inc. (NASDAQ:HROW)April 28, 2025 | marketbeat.comCanada Pension Plan Investment Board Acquires 42,000 Shares of Harrow, Inc. (NASDAQ:HROW)April 26, 2025 | marketbeat.com23,048 Shares in Harrow, Inc. (NASDAQ:HROW) Purchased by Harvest Investment Services LLCApril 25, 2025 | marketbeat.comNORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC.April 24, 2025 | prnewswire.comRussell Investments Group Ltd. Has $1.27 Million Stake in Harrow, Inc. (NASDAQ:HROW)April 22, 2025 | marketbeat.comHarrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...April 21, 2025 | finance.yahoo.comHarrow, Inc. (NASDAQ:HROW) Shares Sold by Renaissance Technologies LLCApril 20, 2025 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Shares Acquired by Franklin Resources Inc.April 17, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCYH, HROW, HCAT, and ADMA Company DescriptionsADMA Biologics NASDAQ:ADMA$20.45 +0.47 (+2.35%) Closing price 04:00 PM EasternExtended Trading$20.40 -0.04 (-0.22%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.Community Health Systems NYSE:CYH$3.88 +0.38 (+10.71%) Closing price 03:59 PM EasternExtended Trading$3.80 -0.07 (-1.83%) As of 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. The company was incorporated in 1996 and is headquartered in Franklin, Tennessee.Health Catalyst NASDAQ:HCAT$4.52 +0.39 (+9.44%) Closing price 04:00 PM EasternExtended Trading$4.53 +0.01 (+0.11%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.Harrow NASDAQ:HROW$26.66 +2.26 (+9.26%) Closing price 04:00 PM EasternExtended Trading$26.48 -0.18 (-0.68%) As of 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Harrow, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in Nashville, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
